Vancouver company’s anti-COVID-19 nasal spray to start clinical trials in U.K.
A Vancouver-based company called SaNOtize has created a nasal spray that it says can stop COVID-19 from spreading throughout the body and even prevent someone from getting the virus.
“The product is a nasal spray that potentially can prevent getting infected … and hopefully also treat the disease early on, in the early stages,” CEO and co-founder Dr. Gilly Regev told Global News Monday.
The product, which uses nitric oxide, will begin clinical trials in the U.K. on Tuesday with patients who have tested positive for COVID-19.
The company has also recently been approved to start clinical trials in the U.S., and has completed the first Phase 2 trial in Canada where none of the 100 people treated with the spray contracted the virus, Regev said.
Anti-COVID-19 nasal spray 'ready for use in humans'
https://globalnews.ca/news/7569565/nasal-spray-covid-19-prevention/
https://www.clinicaltrialsarena.com/news/sanotize-trials-nasal-spray/
No comments:
Post a Comment